Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery

Third molar extraction is a common procedure frequently accompanied by moderate or severe pain, and involves sufficient numbers of patients to make studies relatively easy to perform. The aim of the present study was to determine the efficacy and safety of the therapeutic combination of 10 mg piroxicam, 1 mg dexamethasone, 35 mg orphenadrine citrate, and 2.5 mg cyanocobalamin (Rheumazin®) when compared with 20 mg piroxicam alone (Feldene®) in mandibular third molar surgery. Eighty patients scheduled for removal of the third molar were included in this randomized and double-blind study. They received (vo) Rheumazin or Feldene 30 min after tooth extraction and once daily for 4 consecutive days. Pain was determined by a visual analogue scale and by the need for escape analgesia (paracetamol). Facial swelling was evaluated with a measuring tape and adverse effects and patient satisfaction were recorded. There was no statistically significant difference in facial swelling between Rheumazin and Feldene (control group). Both drugs were equally effective in the control of pain, with Rheumazin displaying less adverse effects than Feldene. Therefore, Rheumazin appears to provide a better risk/benefit ratio in the mandibular molar surgery. Since the side effects resulting from nonsteroidal anti-inflammatory drug administration are a severe limitation to the routine use of these drugs in clinical practice, our results suggest that Rheumazin can be a good choice for third molar removal treatment.

Association between tooth loss and obesity in Brazilian adults: a population-based study

OBJECTIVE: To examine the association between tooth loss and general and central obesity among adults. METHODS: Population-based cross-sectional study with 1,720 adults aged 20 to 59 years from Florianópolis, Southern Brazil. Home interviews were performed and anthropometric measures were taken. Information on sociodemographic data, self-reported diabetes, self-reported number of teeth, central obesity (waist circumference [WC] > 88 cm in women and > 102 cm in men) and general obesity (body mass index [BMI] ≥ 30 kg/m²) was collected. We used multivariable Poisson regression models to assess the association between general and central obesity and tooth loss after controlling for confounders. We also performed simple and multiple linear regressions by using BMI and WC as continuous variables. Interaction between age and tooth loss was also assessed. RESULTS: The mean BMI was 25.9 kg/m² (95%CI 25.6;26.2) in men and 25.4 kg/m2 (95%CI 25.0;25.7) in women. The mean WC was 79.3 cm (95%CI 78.4;80.1) in men and 88.4 cm (95%CI 87.6;89.2) in women. A positive association was found between the presence of less than 10 teeth in at least one arch and increased mean BMI and WC after adjusting for education level, self-reported diabetes, gender and monthly per capita income. However, this association was lost when the variable age was included in the model. The prevalence of general obesity was 50% higher in those with less than 10 teeth in at least one arch when compared with those with 10 or more teeth in both arches after adjusting for education level, self-reported diabetes and monthly per capita family income. However, the statistical significance was lost after controlling for age. CONCLUSIONS: Obesity was associated with number of teeth, though it depended on the participants' age groups.

Gender differences in the association between tooth loss and obesity among older adults in Brazil

OBJECTIVE To analyze if differences according to gender exists in the association between tooth loss and obesity among older adults.METHODS We analyzed data on 1,704 older adults (60 years and over) from the baseline of a prospective cohort study conducted in Florianopolis, SC, Southern Brazil. Multivariable logistic regression models were used to assess the association between tooth loss and general and central obesity after adjustment for confounders (age, gender, skin color, educational attainment, income, smoking, physical activity, use of dentures, hypertension, and diabetes). Linear regressions were also assessed with body mass index and waist circumference as continuous outcomes. Interaction between gender and tooth loss was further assessed.RESULTS Overall mean body mass index was 28.0 kg/m2. Mean waist circumference was 96.8 cm for males and 92.6 cm for females. Increasing tooth loss was positively associated with increased body mass index and waist circumference after adjustment for confounders. Edentates had 1.4 (95%CI 1.1;1.9) times higher odds of being centrally obese than individuals with a higher number of teeth; however, the association lost significance after adjustment for confounders. In comparison with edentate males, edentate females presented a twofold higher adjusted prevalence of general and central obesity. In the joint effects model, edentate females had a 3.8 (95%CI 2.2;6.6) times higher odds to be centrally obese in comparison with males with more than 10 teeth present in both the arches. Similarly, females with less than 10 teeth in at least one arch had a 2.7 (95%CI 1.6;4.4) times higher odds ratio of having central obesity in comparison with males with more than 10 teeth present in both the arches.CONCLUSIONS Central obesity was more prevalent than general obesity among the older adults. We did not observe any association between general obesity and tooth loss. The association between central obesity and tooth loss depends on gender – females with tooth loss had greater probability of being obese.

Dental and facial characteristics of patients with juvenile idiopathic arthritis

OBJECTIVE: It has been shown that the temporomandibular joint is frequently affected by juvenile idiopathic arthritis, and this degenerative disease, which may occur during facial growth, results in severe mandibular dysfunction. However, there are no studies that correlate oral health (tooth decay and gingival diseases) and temporomandibular joint dysfunction in patients with juvenile idiopathic arthritis. The aim of this study is to evaluate the oral and facial characteristics of the patients with juvenile idiopathic arthritis treated in a large teaching hospital. METHOD: Thirty-six patients with juvenile idiopathic arthritis (26 female and 10 male) underwent a systematic clinical evaluation of their dental, oral, and facial structures (DMFT index, plaque and gingival bleeding index, dental relationship, facial profile, and Helkimo's index). The control group was composed of 13 healthy children. RESULTS: The mean age of the patients with juvenile idiopathic arthritis was 10.8 years; convex facial profile was present in 12 juvenile idiopathic arthritis patients, and class II molar relation was present in 12 (P = .032). The indexes of plaque and gingival bleeding were significant in juvenile idiopathic arthritis patients with a higher number of superior limbs joints involved (P = .055). Anterior open bite (5) and temporomandibular joint noise (8) were present in the juvenile idiopathic arthritis group. Of the group in this sample, 94% (P = .017) had temporomandibular joint dysfunction, 80% had decreased mandibular opening (P = 0.0002), and mandibular mobility was severely impaired in 33% (P = .015). CONCLUSION: This study confirms that patients with juvenile idiopathic arthritis a) have a high incidence of mandibular dysfunction that can be attributed to the direct effect of the disease in the temporomandibular joint and b) have a higher incidence of gingival disease that can be considered a secondary effect of juvenile idiopathic arthritis on oral health.

Determinação da massa molar por crioscopia: terc-butanol, um solvente extremamente adequado

We intend to divulge an easy experiment that permits the determination of molar masses of various compounds by cryoscopy. The major advantage of this is the use of the tert-butyl alcohol as a solvent, which requires simple apparatus and easy procedures. The melting point of this alcohol is around 25 ºC, which makes it easy to freeze and then melt the solutions. This solvent has a high cryoscopic constant and is miscible with both polar and non-polar compounds. The molar masses of acetone, water, chloroform, dichloro-methane, ethanol, hexane, carbon tetrachloride and toluene were determined. The results were good except for water. Even though there are reliable techniques of molar mass determination nowadays, this method is still frequently taught in undergraduate courses.

Alargamento da distribuição de massa molar de polímeros sintetizados com catalisadores metalocênicos dual-site

The main topics related to the use of dual-site catalysts in the production of polymers with broad molecular weight distribution are reviewed. The polymerization using dual-site catalysts is more economical and allows to produce a higher quality product than other processes, such as polymer blend and multistage reactors. However, the formulation of these catalysts is quite complicated since the same catalyst must produce distinct polymer grades. In addition, the release of patents concerning the combination of metallocenes and new technologies for polymerization shows that polymerization processes using dual-site catalysts are of current industrial interest.

Relevância de compostos de baixa massa molar produzidos por fungos e envolvidos na biodegradação da madeira

Over the last decade, evidences have been shown that the wood biodegradation by fungi is not only a result of the action of their enzymatic machinery but also of various low molecular weight non-enzymatic compounds, especially in fungi that promote brown and white decay, which in nature are the major wood decaying microorganisms. The present review focuses on the recent theories involving these low molecular weight compounds that act direct or synergistically with lignocellulolytic enzymes to attack the wood main macromolecular constituents, their relevance as potential degradative systems, in the overall wood biodegradation, and also outlines their potential biotechnological applications.

Ácidos orgânicos de baixa massa molar em solos e materiais orgânicos

Determination of organic acids in soils and organic materials is important due to the important role they play in improving the soil's physical, chemical and microbiological conditions. This study identified and quantified low molecular weight organic acids (LMWOA) in soils (dystroferric Red Latosol, dystrophic Red-Yellow Latosol and Quartzarenic Neosol) and organic materials (cow, pig, chicken, quail and horse manures, sawdust, coconut fiber, pine bark, coffee husks, biochar, organic substrate, sewage sludges 1 and 2, garbage compost, pig slurry compost). The following acids were identified: acetic, citric, D-malic, formic, fumaric, maleic, malonic, oxalic, quinic, shikimic, succinic and tartaric.

Pressão interna e refração molar dos sistemas dimetilsulfóxido + tiofeno, dimetilsulfóxido + piridina a 298,15K

Pressão interna, volume livre, refração molar e propriedades termodinâmicas de excesso de misturas líquidas binárias de dimetil sulfóxido + tiofeno e dimetil sulfóxido + piridina a 298.15K foram calculadas a partir de medidas experimentais de densidades, tensão superficial e índice de refração. A relação entre a pressão interna, volume molar de excesso, refração molar, e a interação molecular dos sistemas binários é examinada.

Mudanças na apresentação clínica da gravidez molar

OBJETIVO: determinar se a apresentação clínica da mola hidatiforme tem mudado nos últimos anos (1992-1998) quando comparada a registros históricos de controle (1960-1981). MÉTODOS: foram revisadas 80 fichas de pacientes com mola hidatiforme acompanhadas entre 1960-1981 no Centro de Neoplasia Trofoblástica Gestacional da Santa Casa da Misericórdia (Rio de Janeiro Brasil) e as de 801 pacientes atendidas entre 1992-1998 no mesmo centro. Foram analisados os seguintes parâmetros: idade, número de gestações, sangramento vaginal, hiperêmese, edema dos membros inferiores, hipertensão arterial, útero grande para a idade gestacional e cistos teca-luteínicos dos ovários. Para análise estatística foram utilizados os testes do qui-quadrado e o cálculo do odds ratio (OR) com intervalo de confiança (IC) de 95%. RESULTADOS: com relação à idade, a ocorrência de mola em pacientes com menos de 15 anos ou mais de 40 foi significativamente mais freqüente no grupo II do que no grupo I; quanto ao número de gestações, a diferença entre os dois grupos só não foi significativa entre aquelas pacientes que gestavam pela terceira e quarta vez. A hipertensão arterial, foi detectada em porcentagem semelhante nos dois grupos e útero grande para a idade gestacional foi mais freqüente no grupo II (41,4 vs 31,2% - p <0,05; OR: 1,5; IC: 1,0-2,3). Todos os outros elementos clínicos foram menos freqüentes no grupo II do que no grupo I. O sangramento vaginal permaneceu o elemento clínico mais freqüente, ocorrendo em 76,9% das pacientes do grupo II e 98,7% das pacientes do grupo I (p < 0,05; OR: 0,04; IC: 0,030,04). Também foram menos freqüente no grupo II quando comparado com grupo I a hiperêmese (36,5% vs 45% - p < 0,05; OR: 0,7; IC: 0,40,9); edema (12,7% vs 20% - p < 0,05; OR: 0,5; IC: 0,30,8); e cistose ovariana (16,4 vs 41,2% - p < 0,05 OR: 0,3; IC: 0,20,4). A ultra-sonografia foi o meio diagnóstico mais comum (89,2%), e o grande responsável pelo rastreio precoce da gravidez molar. CONCLUSÃO: concluiu-se haver diminuição da sintomatologia tradicional nas pacientes com mola hidatiforme quando comparadas a controle histórico, devendo-se o fato ao diagnóstico precoce proporcionado pela ultra-sonografia.

A curva de regressão da gonadotrofina coriônica humana é útil no diagnóstico precoce da neoplasia trofoblástica gestacional pós-molar?

OBJETIVO: avaliar a utilidade da curva de regressão normal da gonadotrofina coriônica humana (hCG) no diagnóstico precoce de neoplasia trofoblástica gestacional pós-molar (NTG). MÉTODOS: estudo longitudinal, incluindo 105 pacientes com mola hidatiforme completa (MHC) acompanhadas no Centro de Doenças Trofoblásticas de Botucatu, entre 1998 e 2005. Os títulos da hCG sérica foram mensurados quinzenalmente em todas as pacientes. Curvas individuais de regressão da hCG das 105 pacientes foram estabelecidas. A comparação entre a curva de regressão normal estabelecida em nosso serviço com as curvas individuais da hCG foi usada no rastreamento e diagnóstico (platô/ascensão) de NTG. O número de semanas pós-esvaziamento quando a hCG excedeu o limite normal foi comparado com o número semanas em que a hCG apresentou platô/ascensão. RESULTADOS: das 105 pacientes com MHC, 80 apresentaram remissão espontânea (RE) e 25 desenvolveram NTG. Das 80 pacientes com RE, 7 (8,7%) apresentaram, inicialmente, dosagem da hCG acima do normal, mas, no devido tempo, alcançaram a remissão. Todas as 25 pacientes com NTG apresentaram desvio da curva normal da hCG em 3,8±2,5 semanas e mostraram platô ou ascensão em 8,4±2,9 semanas (p<0,001). CONCLUSÕES: a curva de regressão normal da hCG pós-molar pode ser útil para diagnóstico de NTG.

Risco da ocorrência de neoplasia trofoblástica gestacional após a normalização da gonadotrofina coriônica humana no seguimento pós-molar

Dissertação apresentada ao Curso de Mestrado Profissional em Saúde Materno-Infantil da Universidade Federal Fluminense, como requisito para obtenção do grau de Mestre em Saúde Materno-Infantil. Área de Concentração: Saúde da Mulher e da Criança, em 16 de maio de 2014.OBJETIVO: avaliar o risco da ocorrência de neoplasia trofoblástica gestacional (NTG) após a normalização da gonadotrofina coriônica humana (hCG) no seguimento pós-molar. PACIENTES E MÉTODOS: trata-se de estudo retrospectivo, tipo coorte não concorrente, colaborativo interinstitucional, realizado nos Centros de Referência em Doença Trofoblástica Gestacional da SCMRJ, HUAP-UFF, ME-UFRJ, HC-UNESP e HC-UFG. Foram analisados dos prontuários médicos de pacientes acompanhadas nesses Serviços, entre os anos de 2002 e 2013. Esse projeto foi aprovado pelo Comitê de Ética em Pesquisa. RESULTADOS: entre as pacientes que cursaram com remissão espontânea, 10 (0,4% - 1 em cada 201 casos de MH) evoluíram com NTG após a normalização de hCG (p<0,0001; IC95% 0,2–0,7). Quando se analisa o risco de NTG após a normalização de hCG nos diferentes tipos de gravidez molar, observou-se sua ocorrência em 9/2016 (0,4% - 1 em cada 224 casos) dentre as pacientes com mola hidatiforme completa - MHC (p<0,0001; IC95% 0,2–0,7), de 1/982 (0,1% - 1 em cada 985 casos) dentre as pacientes com mola hidatiforme parcial - MHP (p<0,0001; IC95% 0,02–0,5) e em nenhuma das pacientes com gravidez molar gemelar - GMG. Consoante o tempo de normalização de hCG, a ocorrência de NTG foi observada em 1/1595 (0,06% - 1 em cada 1595 casos de MH) das pacientes cujo hCG normalizou com menos de 56 dias (p<0,0001; IC95% 0,01–0,3), enquanto que entre aquelas cujo hCG normalizou com mais de 56 dias a NTG ocorreu em 9/1416 (0,6% - 1 em cada 157 casos de MH) das pacientes (p<0,0001; IC95% 0,3–1,1), exibindo um OR de 10,19 (p=0,02; IC95% 1,29–80,58). CONCLUSÕES: o risco de NTG após a normalização de hCG é ínfimo. Parece-nos razoável que seja dada alta para a paciente com MHP após a primeira dosagem normal de hCG. Nos casos de MHC e GMG, esse seguimento deve ser mantido por 6 meses.

Thr(118)Met amino acid substitution in the peripheral myelin protein 22 does not influence the clinical phenotype of Charcot-Marie-Tooth disease type 1A due to the 17p11.2-p12 duplication

The Thr(118)Met substitution in the peripheral myelin protein 22 (PMP22) gene has been detected in a number of families with demyelinating Charcot-Marie-Tooth (CMT1) neuropathy or with the hereditary neuropathy with liability to pressure palsy, but in none of them has it consistently segregated with the peripheral neuropathy. We describe here a CMT1 family (a 63-year-old man, his brother and his niece) in which two mutations on different chromosomes were found in the PMP22 gene, the 17p duplication, detected by fluorescent semiquantitative polymerase chain reaction (PCR) of microsatellite markers localized within the duplicated region on chromosome 17p11.2-p12, and the Thr(118)Met substitution, detected by direct sequencing the four coding exons of the PMP22 gene. A genotype/phenotype correlation study showed that the neuropathy segregates with the duplication and that the amino acid substitution does not seem to modify the clinical characteristics or the severity of the peripheral neuropathy. We did not find any evidence to characterize this substitution as a polymorphism in the population studied and we propose that the high frequency reported for this point mutation in the literature suggests that the Thr(118)Met substitution may be a hotspot for mutations in the PMP22 gene.

The selective and non-selective cyclooxygenase inhibitors valdecoxib and piroxicam induce the same postoperative analgesia and control of trismus and swelling after lower third molar removal

We compared the clinical efficacy of orally administered valdecoxib and piroxicam for the prevention of pain, trismus and swelling after removal of horizontally and totally intrabony impacted lower third molars. Twenty-five patients were scheduled to undergo removal of symmetrically positioned lower third molars in two separate appointments. Valdecoxib (40 mg) or piroxicam (20 mg) was administered in a double-blind, randomized and crossed manner for 4 days after the surgical procedures. Objective and subjective parameters were recorded for comparison of postoperative courses. Both agents were effective for postoperative pain relief (N = 19). There was a similar mouth opening at suture removal compared with the preoperative values (86.14 ± 4.36 and 93.12 ± 3.70% of the initial measure for valdecoxib and piroxicam, respectively; ANOVA). There was no significant difference regarding the total amount of rescue medication taken by the patients treated with valdecoxib or piroxicam (173.08 ± 91.21 and 461.54 ± 199.85 mg, respectively; Wilcoxon test). There were no significant differences concerning the swelling observed on the second postoperative day compared to baseline measures (6.15 ± 1.84 and 8.46 ± 2.04 mm for valdecoxib and piroxicam, respectively; ANOVA) or on the seventh postoperative day (1.69 ± 1.61 and 2.23 ± 2.09 mm for valdecoxib and piroxicam, respectively; ANOVA). The cyclooxygenase-2 selective inhibitor valdecoxib is as effective as the non-selective cyclooxygenase inhibitor piroxicam for pain, trismus and swelling control after removal of horizontally and totally intrabony impacted lower third molars.